MediciNova Inc. (MNOV)
Symbol Info
Listed Symbol MNOV
Name MediciNova Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-0.37
Price Info
21 Day Moving Average $7.4991
21 Day EMA $7.582150
50 Day Moving Average $8.1582
50 Day EMA $8.106990
200 Day EMA $9.091580
200 Day Moving Average 9.258300
52 Week High $13.37
52 Week Low $6.68
52 Week Change $-27.551000
Alpha 0.014659
Beta 1.2242
Standard Deviation 0.150511
R2 0.078016
Periods 60
Share Information
10 Day Average Volume 125,332
20 Day Average Volume 84,909
30 Day Average Volume 89,980
50 Day Average Volume 85,595
Outstanding Shares 43,357,242
Float Shares 40,447,340
Percent Float 93.29%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 121
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 663,691
Institute Holdings Percent 34.600000
Institute Sold Previous 3 Months 742,571
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 6
Insider Holdings Percent 6.70%
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,909,902
Price Change
7 Day Price Change $0.4099999
7 Day Percent Change 5.54%
21 Day Price Change $0.0900002
21 Day Percent Change 1.17%
30 Day Price Change $-0.4699998
30 Day Percent Change -5.68%
Month To Date Price Change $-0.145
Month To Date Percent -1.82%
90 Day Price Change $-1.83
90 Day Percent Change -18.98%
Quarter To Date $-0.145
Quarter To Date Percent -1.82%
180 Day Price Change $-1.41
180 Day Percent Change -15.29%
200 Day Price Change $-0.48
200 Day Percent Change -5.79%
Year To Date $-0.36
Year To Date Percent -4.41%
Profile
Description MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.
Details
Issue Type CS
Market Cap $338,620,060
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 43,357,242
CEO Yuichi Iwaki
Employees 9
Last Audit UQ
Classification
CIK 0001226616
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 4275 Executive Square
Suite 300
La Jolla, CA 92037
Website http://www.medicinova.com
Facisimile +1 858 404-0048
Telephone +1 858 373-1500
Email info@medicinova.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $283,169,018
Price To Sales -
Price To Free Cash -51.4
PE High Last 5 Years -
Price To Book 4.5
Price To Cash Flow 116.1
PE Low Last 5 Years -
Price To Tangible Book 5.5
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 34.8
Leverage Ratio 1.1
Quick Ratio 34.5
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -19.93
Return On Equity -20.93
Return On Capital -22.5
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
MNOV
Medicinova
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.